Gilmore BF - Search Results

1

Novel inhibitors of the Pseudomonas aeruginosa virulence factor LasB: a potential therapeutic approach for the attenuation of virulence mechanisms in pseudomonal infection.

Cathcart GR, Quinn D, Greer B, Harriott P, Lynas JF, Gilmore BF, Walker B. Cathcart GR, et al. Among authors: gilmore bf. Antimicrob Agents Chemother. 2011 Jun;55(6):2670-8. doi: 10.1128/AAC.00776-10. Epub 2011 Mar 28. Antimicrob Agents Chemother. 2011. PMID: 21444693 Free PMC article.

2

The inactivation of bovine cathepsin B by novel N-chloro-acetyl-dipeptides: application of the Houghten 'tea bag' methodology to inhibitor synthesis.

Gilmore BF, Harriott P, Walker B. Gilmore BF, et al. Biochem Biophys Res Commun. 2005 Aug 12;333(4):1284-8. doi: 10.1016/j.bbrc.2005.06.033. Biochem Biophys Res Commun. 2005. PMID: 15978544

3

Dipeptide proline diphenyl phosphonates are potent, irreversible inhibitors of seprase (FAPalpha).

Gilmore BF, Lynas JF, Scott CJ, McGoohan C, Martin L, Walker B. Gilmore BF, et al. Biochem Biophys Res Commun. 2006 Jul 28;346(2):436-46. doi: 10.1016/j.bbrc.2006.05.175. Biochem Biophys Res Commun. 2006. PMID: 16769036

4

Peptides containing acylated C-terminal gem diamines: novel irreversible inactivators of the cysteine and serine proteinases.

Gilmore BF, Lynas JF, Harriott P, Healy A, Walker B. Gilmore BF, et al. Chem Biol Drug Des. 2006 May;67(5):364-9. doi: 10.1111/j.1747-0285.2006.00390.x. Chem Biol Drug Des. 2006. PMID: 16784461

5

Synthesis, kinetic evaluation, and utilization of a biotinylated dipeptide proline diphenyl phosphonate for the disclosure of dipeptidyl peptidase IV-like serine proteases.

Gilmore BF, Carson L, McShane LL, Quinn D, Coulter WA, Walker B. Gilmore BF, et al. Biochem Biophys Res Commun. 2006 Aug 18;347(1):373-9. doi: 10.1016/j.bbrc.2006.06.113. Epub 2006 Jun 27. Biochem Biophys Res Commun. 2006. PMID: 16824486

6

Synthesis of peptidyl ene diones: selective inactivators of the cysteine proteinases.

Darkins P, Gilmore BF, Hawthorne SJ, Healy A, Moncrieff H, McCarthy N, McKervey MA, Brömme D, Pagano M, Walker B. Darkins P, et al. Among authors: gilmore bf. Chem Biol Drug Des. 2007 Mar;69(3):170-9. doi: 10.1111/j.1747-0285.2007.00490.x. Chem Biol Drug Des. 2007. PMID: 17441903

7

Inhibitor profiling of the Pseudomonas aeruginosa virulence factor LasB using N-alpha mercaptoamide template-based inhibitors.

Cathcart GR, Gilmore BF, Greer B, Harriott P, Walker B. Cathcart GR, et al. Among authors: gilmore bf. Bioorg Med Chem Lett. 2009 Nov 1;19(21):6230-2. doi: 10.1016/j.bmcl.2009.08.099. Epub 2009 Sep 10. Bioorg Med Chem Lett. 2009. PMID: 19773163

8

Expedited solid-phase synthesis of fluorescently labeled and biotinylated aminoalkane diphenyl phosphonate affinity probes for chymotrypsin- and elastase-like serine proteases.

Gilmore BF, Quinn DJ, Duff T, Cathcart GR, Scott CJ, Walker B. Gilmore BF, et al. Bioconjug Chem. 2009 Nov;20(11):2098-105. doi: 10.1021/bc9002162. Bioconjug Chem. 2009. PMID: 19810697

9

Gene delivery using dimethyldidodecylammonium bromide-coated PLGA nanoparticles.

Fay F, Quinn DJ, Gilmore BF, McCarron PA, Scott CJ. Fay F, et al. Among authors: gilmore bf. Biomaterials. 2010 May;31(14):4214-22. doi: 10.1016/j.biomaterials.2010.01.143. Epub 2010 Feb 24. Biomaterials. 2010. PMID: 20185174

10

Comprehensive inhibitor profiling of the Proteus mirabilis metalloprotease virulence factor ZapA (mirabilysin).

Carson L, Cathcart GR, Scott CJ, Hollenberg MD, Walker B, Ceri H, Gilmore BF. Carson L, et al. Among authors: gilmore bf. Biochimie. 2011 Oct;93(10):1824-7. doi: 10.1016/j.biochi.2011.06.030. Epub 2011 Jul 6. Biochimie. 2011. PMID: 21762758

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

156 results

Search Page

Filters